Holers VM - Search Results

1

Complement receptor 2-mediated targeting of complement inhibitors to sites of complement activation.

Song H, He C, Knaak C, Guthridge JM, Holers VM, Tomlinson S. Song H, et al. Among authors: holers vm. J Clin Invest. 2003 Jun;111(12):1875-85. doi: 10.1172/JCI17348. J Clin Invest. 2003. PMID: 12813023 Free PMC article.

2

Characterization of a complement receptor 2 (CR2, CD21) ligand binding site for C3. An initial model of ligand interaction with two linked short consensus repeat modules.

Molina H, Perkins SJ, Guthridge J, Gorka J, Kinoshita T, Holers VM. Molina H, et al. Among authors: holers vm. J Immunol. 1995 May 15;154(10):5426-35. J Immunol. 1995. PMID: 7730644

3

Characterization of C3 receptors on cultured rat glomerular endothelial cells.

Alexander JJ, He C, Adler S, Holers VM, Quigg RJ. Alexander JJ, et al. Among authors: holers vm. Kidney Int. 1997 Apr;51(4):1124-32. doi: 10.1038/ki.1997.155. Kidney Int. 1997. PMID: 9083278 Free article.

4

Characterization of C3-binding proteins on mouse neutrophils and platelets.

Quigg RJ, Alexander JJ, Lo CF, Lim A, He C, Holers VM. Quigg RJ, et al. Among authors: holers vm. J Immunol. 1997 Sep 1;159(5):2438-44. J Immunol. 1997. PMID: 9278336

5

Transgenic mice overexpressing the complement inhibitor crry as a soluble protein are protected from antibody-induced glomerular injury.

Quigg RJ, He C, Lim A, Berthiaume D, Alexander JJ, Kraus D, Holers VM. Quigg RJ, et al. Among authors: holers vm. J Exp Med. 1998 Oct 5;188(7):1321-31. doi: 10.1084/jem.188.7.1321. J Exp Med. 1998. PMID: 9763611 Free PMC article.

6

Gamma-glutamyl transpeptidase, an ecto-enzyme regulator of intracellular redox potential, is a component of TM4 signal transduction complexes.

Nichols TC, Guthridge JM, Karp DR, Molina H, Fletcher DR, Holers VM. Nichols TC, et al. Among authors: holers vm. Eur J Immunol. 1998 Dec;28(12):4123-9. doi: 10.1002/(SICI)1521-4141(199812)28:12<4123::AID-IMMU4123>3.0.CO;2-G. Eur J Immunol. 1998. PMID: 9862348 Free article.

7

Renal, central nervous system and pancreatic overexpression of recombinant soluble Crry in transgenic mice. A novel means of protection from complement-mediated injury.

Alexander JJ, Lim A, He C, MacDonald RL, Holers VM, Quigg RJ. Alexander JJ, et al. Among authors: holers vm. Immunopharmacology. 1999 May;42(1-3):245-54. doi: 10.1016/s0162-3109(99)00010-7. Immunopharmacology. 1999. PMID: 10408385

8

Modulation of renal disease in MRL/lpr mice genetically deficient in the alternative complement pathway factor B.

Watanabe H, Garnier G, Circolo A, Wetsel RA, Ruiz P, Holers VM, Boackle SA, Colten HR, Gilkeson GS. Watanabe H, et al. Among authors: holers vm. J Immunol. 2000 Jan 15;164(2):786-94. doi: 10.4049/jimmunol.164.2.786. J Immunol. 2000. PMID: 10623824

9

Complement is activated in kidney by endotoxin but does not cause the ensuing acute renal failure.

Cunningham PN, Holers VM, Alexander JJ, Guthridge JM, Carroll MC, Quigg RJ. Cunningham PN, et al. Among authors: holers vm. Kidney Int. 2000 Oct;58(4):1580-7. doi: 10.1046/j.1523-1755.2000.00319.x. Kidney Int. 2000. PMID: 11012892 Free article.

10

Structural studies in solution of the recombinant N-terminal pair of short consensus/complement repeat domains of complement receptor type 2 (CR2/CD21) and interactions with its ligand C3dg.

Guthridge JM, Rakstang JK, Young KA, Hinshelwood J, Aslam M, Robertson A, Gipson MG, Sarrias MR, Moore WT, Meagher M, Karp D, Lambris JD, Perkins SJ, Holers VM. Guthridge JM, et al. Among authors: holers vm. Biochemistry. 2001 May 22;40(20):5931-41. doi: 10.1021/bi0101749. Biochemistry. 2001. PMID: 11352728

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

434 results

Search Page

Filters